Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity.

Yang JY, Li X, Gao L, Teng ZH, Liu WC.

Exp Ther Med. 2012 Oct;4(4):655-660. Epub 2012 Jul 6.

PMID:
23170121
2.
3.

Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.

Yang JY, Cao DY, Xue Y, Yu ZC, Liu WC.

Hum Immunol. 2010 Mar;71(3):255-62. doi: 10.1016/j.humimm.2009.12.010. Epub 2010 Jan 8.

PMID:
20036295
4.
5.

Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.

Zhang HM, Zhang LW, Ren J, Fan L, Si XM, Liu WC.

Cell Immunol. 2006 Feb;239(2):144-50. Epub 2006 Jun 30.

PMID:
16814271
6.

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.

González-Carmona MA, Märten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf IG, Sauerbruch T, Caselmann WH.

Liver Int. 2006 Apr;26(3):369-79.

PMID:
16584401
7.
8.
9.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
10.

Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100.

Xia DJ, Zhang WP, Zheng S, Wang J, Pan JP, Wang Q, Zhang LH, Hamada H, Cao X.

Gene Ther. 2002 May;9(9):592-601.

PMID:
11973635
11.

Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.

Sun L, Guo H, Jiang R, Lu L, Liu T, He X.

Tumour Biol. 2016 Jan;37(1):799-806. doi: 10.1007/s13277-015-3845-9. Epub 2015 Aug 7.

PMID:
26250457
12.

[Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma].

Zeng B, Lu FG, Liu XW, Yang DY, Fang WY, Wang J, Liao AJ, Shi W.

Ai Zheng. 2005 Nov;24(11):1332-7. Chinese.

PMID:
16552958
13.

Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.

Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.

Cancer Res. 2001 Oct 15;61(20):7563-7.

PMID:
11606395
14.

Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses.

Schumacher L, Ribas A, Dissette VB, McBride WH, Mukherji B, Economou JS, Butterfield LH.

J Immunother. 2004 May-Jun;27(3):191-200.

PMID:
15076136
15.

Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.

Kalady MF, Onaitis MW, Emani S, Abdel-Wahab Z, Tyler DS, Pruitt SK.

J Surg Res. 2004 Jan;116(1):24-31.

PMID:
14732346
16.

Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.

Ren J, Jia J, Zhang H, Zhang L, Ma B, Jiang H, Di L, Song G, Yu J.

Cancer Sci. 2008 Jul;99(7):1420-6. doi: 10.1111/j.1349-7006.2008.00820.x. Epub 2008 Apr 16.

PMID:
18422751
17.

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

Suzuki T, Fukuhara T, Tanaka M, Nakamura A, Akiyama K, Sakakibara T, Koinuma D, Kikuchi T, Tazawa R, Maemondo M, Hagiwara K, Saijo Y, Nukiwa T.

Clin Cancer Res. 2005 Jan 1;11(1):58-66.

PMID:
15671528
18.

Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.

Liu Y, Zhang X, Zhang W, Chen Z, Chan T, Ali K, Jia Z, Xiang J.

Cancer Gene Ther. 2002 Feb;9(2):202-8.

PMID:
11857039
19.

[Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].

Pang XH, Chen MS, Jia WH, Zhou XX.

Ai Zheng. 2008 Dec;27(12):1233-8. Chinese.

PMID:
19079985

Supplemental Content

Support Center